Subscribe to Newsletter

Drug Discovery

Business & Regulation Standards & Regulation

AMF’s 2026 AMR Strategy, Revealed

| Rob Coker | 3 min read

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Discovery & Development Drug Discovery

A New Computational Approach to Complex Molecule Synthesis

| Stephanie Vine | 8 min read

Early work from Scripps researchers uses a virtual library to synthesize plant-based metabolites: picrotoxanes.

Discovery & Development Drug Discovery

Breast Cancer Breakthrough

| Rob Coker

Scientists develop treatment that leads to complete regression of breast tumors in mice.

Business & Regulation Standards & Regulation

Researchers Respond to NIH Funding Cuts

| Stephanie Vine | 4 min read

Stakeholders explain why the NIH’s move to cap indirect costs associated with research grants could damage medical innovation.

Discovery & Development Drug Discovery

Venom: The Last Advance

| Rob Coker | 2 min read

How snake venom, genomic data, and deep learning computation methods have combined to bring new advances in drug discovery.

Discovery & Development Drug Discovery

Examining the Effectiveness of Antidepressants

| Stephanie Vine | 2 min read

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

Manufacture Vaccines

Understanding the H5N1 Threat

| Stephanie Vine | 4 min read

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

Discovery & Development Clinical Trials

AI in Oncology: The Bridge Between the Patient and the Practice

| 2 min read

Using AI to improve oncology care and find the right clinical trials for patients.

Discovery & Development Drug Discovery

The Trick With Senolytics

| 4 min read

How understanding and manipulating senescence dynamics could optimize cancer therapies and improve patient outcomes.

Discovery & Development Advanced Medicine

Complex DNA; No Compromises

| Daniel Lin-Arlow | 4 min read

How can you ensure your gene therapy research won’t be slowed down by synthesis problems?


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register